PDCD1 and neoplasm: Future studies investigating the interaction of E3 ligases with the tumor intrinsic PD-1/PD-L1 signaling pathway may provide new insights into ICT and facilitate the development of more effective combined immunotherapy to improve the efficacy of immunotherapy.